Head and Neck Squamous Cell Carcinoma Clinical Trials in Singapore
3 recruitingSingapore, Singapore
Showing 1–3 of 3 trials
Recruiting
Phase 1
A Study to Test Whether Treatment With BI 770371 in Combination With Pembrolizumab With or Without Cetuximab Helps People With Head and Neck Cancer Compared With Pembrolizumab Alone
Head and Neck Squamous Cell Carcinoma
Boehringer Ingelheim90 enrolled57 locationsNCT06806852
Recruiting
Phase 1Phase 2
Study of an Anti-HER3 Antibody, HMBD-001, With Docetaxel +/- Cetuximab in Advanced Squamous Non-small Cell Lung Cancers, and HMBD-001 + Cetuximab in Advanced Squamous Cell Cancers
Advanced or Metastatic Squamous Non-Small Cell Lung CancerAdvanced Head and Neck Squamous Cell CarcinomaAdvanced Esophageal Squamous Cell Carcinoma+2 more
Hummingbird Bioscience98 enrolled20 locationsNCT05910827
Recruiting
Phase 2
A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced Cancers
Non-small Cell Lung CancerHead and Neck Squamous Cell CarcinomaCarcinoma, Hepatocellular+3 more
National University Hospital, Singapore360 enrolled1 locationNCT06422403